6Higashi H,Natsugoe S,Ishigami S.Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion[J].World J Surg,2003,27(4):455 -459.
7Yasuda K,Adachi Y,Shiraishi N,et al.Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer[J].Ann Surg Oncol,2002,9(8):771 -774.
8Lee E,Chae Y,Kim I.Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma[J].Cancer,2002,94(11):2867-2873.
2Moll R, l.owe A, Laufer J, et al. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol, 1992,140:427-447.
3Denis MG, Lipart C, Leborgne J, et al. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer,1997,74: 540-544.
4Lindemann F, Schlimok G, Diischedl P, et al. Prognostic significance micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet, 1992,340: 685-689.
5Wyld DK, Selby P, Perren TJ, et al. Detection of colorectal cancer cells in peripheral blood by reverse- transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer, 1998.79:288-293.
6Funaki NO, Tanaka J, Itami A, et al. Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokemtin-20 mRNA. Life Sci, 1997,60:643-652.
7Matsushita M, Hajiro K, Suzaki T, et al. Histopathological assessment of lymph node metastasis in patients with gastric cancer. Hepatogastroenterology,1995,42:861-866.
8Sasaki M, Watanabe H, Jass JR, et al. Occult lymph node metastasis detected by cytokeratin immunohistochemistry predict recurrence in "node negative" colorectal cancer. J Gastroenterol, 1997, 32:758-764.
9Sedmak DD, Meineke TA, Knechtges DS, et al. Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins. Arch Pathol Lab Med, 1989, 113:786-789.
10Cai J, Ikeguchi M, Maeta M, et al. Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer. Gastric Cancer, 1999,2:95-100.
